Latest news with #FenixResources
Yahoo
7 days ago
- Business
- Yahoo
ASX Growth Companies With High Insider Ownership June 2025
As the Australian market faces a slight downturn, influenced by global trade uncertainties and energy developments, investors are keenly observing the ASX 200's movements amid fluctuating international dynamics. In this environment, growth companies with high insider ownership can often be appealing due to their potential for strong alignment between management and shareholder interests, especially when navigating complex market conditions. Name Insider Ownership Earnings Growth Alfabs Australia (ASX:AAL) 10.8% 41.3% Brightstar Resources (ASX:BTR) 11.6% 106.7% Fenix Resources (ASX:FEX) 21.1% 53.4% Acrux (ASX:ACR) 15.6% 106.9% Cyclopharm (ASX:CYC) 11.3% 97.8% Echo IQ (ASX:EIQ) 19.8% 65.9% Newfield Resources (ASX:NWF) 31.5% 72.1% Titomic (ASX:TTT) 11.2% 77.2% Image Resources (ASX:IMA) 20.6% 79.9% Findi (ASX:FND) 29.1% 139.5% Click here to see the full list of 97 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★★☆ Overview: Chrysos Corporation Limited develops and supplies mining technology, with a market cap of A$597.99 million. Operations: Chrysos Corporation Limited generates revenue primarily from its Mining Services segment, amounting to A$55.51 million. Insider Ownership: 17.6% Chrysos is positioned for significant growth with an expected annual revenue increase of 27.8%, outpacing the Australian market's 5.7%. Despite having less than a year of cash runway, its forecasted profitability within three years suggests robust potential. Earnings are anticipated to grow at 58.15% annually, although return on equity remains low at 6.9%. Recent conference presentations indicate active engagement with investors, but no substantial insider trading activity was noted over the past three months. Unlock comprehensive insights into our analysis of Chrysos stock in this growth report. According our valuation report, there's an indication that Chrysos' share price might be on the expensive side. Simply Wall St Growth Rating: ★★★★★★ Overview: Develop Global Limited, along with its subsidiaries, focuses on the exploration and development of mineral resource properties in Australia and has a market cap of A$1.10 billion. Operations: The company generates revenue primarily from its mining services segment, which amounts to A$194.45 million. Insider Ownership: 20.7% Develop Global is set for substantial growth, with revenue projected to rise by 47.5% annually, significantly outpacing the Australian market's 5.7%. The company is expected to achieve profitability within three years, with earnings forecasted to grow at a robust 90.32% per year. Trading at a good value relative to peers and industry benchmarks, Develop Global's return on equity is anticipated to reach a high of 25.5%, underscoring its strong growth potential without recent insider trading activity impacting sentiment. Click to explore a detailed breakdown of our findings in Develop Global's earnings growth report. According our valuation report, there's an indication that Develop Global's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Universal Store Holdings Limited is an Australian company that designs, wholesales, and retails fashion products for men and women, with a market cap of A$596.12 million. Operations: The company generates revenue primarily through its Universal Store segment, which accounts for A$287.13 million, and the CTC segment contributing A$41.29 million. Insider Ownership: 14.1% Universal Store Holdings is positioned for growth, with its revenue expected to increase by 8.8% annually, surpassing the Australian market's 5.7%. Despite trading at 64.3% below fair value estimates, recent substantial insider selling could raise concerns. Earnings are forecasted to grow at 18.48% per year, outpacing the market's 11.8%, though not significantly high by some standards. Analysts anticipate a stock price rise of 27.6%, but dividend sustainability remains questionable with coverage issues present amidst these forecasts and activities. Dive into the specifics of Universal Store Holdings here with our thorough growth forecast report. Our comprehensive valuation report raises the possibility that Universal Store Holdings is priced lower than what may be justified by its financials. Click this link to deep-dive into the 97 companies within our Fast Growing ASX Companies With High Insider Ownership screener. Ready For A Different Approach? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:C79 ASX:DVP and ASX:UNI. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
16-04-2025
- Business
- Yahoo
3 ASX Growth Companies With Up To 23% Insider Ownership
As the Australian market navigates a period of slower trade and investor caution amid ongoing global tensions, identifying growth companies with significant insider ownership can offer valuable insights into potential investment opportunities. In this environment, where confidence is tempered by geopolitical uncertainties, stocks with strong insider commitment may signal a higher level of trust in the company's long-term prospects. Name Insider Ownership Earnings Growth Alfabs Australia (ASX:AAL) 10.8% 41.3% Fenix Resources (ASX:FEX) 21.1% 47.8% Cyclopharm (ASX:CYC) 11.3% 97.8% Acrux (ASX:ACR) 15.5% 106.9% Newfield Resources (ASX:NWF) 31.5% 72.1% Echo IQ (ASX:EIQ) 19.8% 111.1% Titomic (ASX:TTT) 11.2% 77.2% Plenti Group (ASX:PLT) 12.7% 85% Image Resources (ASX:IMA) 16.1% 127.3% BETR Entertainment (ASX:BBT) 38.6% 77.5% Click here to see the full list of 93 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Aurelia Metals Limited is an Australian company involved in the exploration and production of mineral properties, with a market capitalization of A$456.99 million. Operations: The company's revenue is primarily derived from its operations at the Peak Mine (A$245.13 million), Dargues Mine (A$73.90 million), and Hera Mine (A$5.98 million). Insider Ownership: 23.9% Aurelia Metals shows promise as a growth company with substantial insider ownership, evidenced by significant insider buying in recent months. The company has returned to profitability, reporting A$17.95 million net income for the half-year ending December 2024 compared to a loss previously. While gold and silver production declined, copper output increased significantly. Analysts forecast robust annual earnings growth of 23.6%, outpacing the broader Australian market's expected growth rate of 11.7%. Unlock comprehensive insights into our analysis of Aurelia Metals stock in this growth report. The valuation report we've compiled suggests that Aurelia Metals' current price could be quite moderate. Simply Wall St Growth Rating: ★★★★★☆ Overview: Clarity Pharmaceuticals Ltd is a clinical stage radiopharmaceutical company focused on research and development of radiopharmaceutical products in Australia and the United States, with a market cap of A$539.87 million. Operations: The company's revenue segment consists of Radiopharmaceutical Development, generating A$10.78 million. Insider Ownership: 17.8% Clarity Pharmaceuticals demonstrates strong growth potential, driven by its innovative Cu-SAR-bisPSMA platform for prostate cancer treatment. Recent trial advancements show promising efficacy and safety, with significant PSA reductions in heavily pre-treated participants. The FDA's Fast Track Designation supports accelerated development. Despite a net loss of A$23.58 million for the half-year ending December 2024, revenue grew to A$10.94 million from A$6.52 million year-over-year, with forecasts indicating rapid revenue growth exceeding market averages. Take a closer look at Clarity Pharmaceuticals' potential here in our earnings growth report. Our valuation report here indicates Clarity Pharmaceuticals may be overvalued. Simply Wall St Growth Rating: ★★★★★★ Overview: IperionX Limited is involved in the exploration and development of mineral properties in the United States, with a market capitalization of approximately A$900.03 million. Operations: IperionX Limited's revenue segments are not specified in the provided text. Insider Ownership: 19.2% IperionX is poised for significant growth, driven by its Titan Critical Minerals Project in Tennessee and strategic U.S. partnerships, including a USD 47.1 million government award to enhance the titanium supply chain. Despite recent shareholder dilution and a net loss of USD 16.24 million for the half-year ending December 2024, IperionX's revenue is forecast to grow rapidly, outpacing market averages with expected profitability within three years, supported by innovative technologies and substantial insider ownership. Click here to discover the nuances of IperionX with our detailed analytical future growth report. Our comprehensive valuation report raises the possibility that IperionX is priced higher than what may be justified by its financials. Click through to start exploring the rest of the 90 Fast Growing ASX Companies With High Insider Ownership now. Contemplating Other Strategies? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:AMI ASX:CU6 and ASX:IPX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
16-04-2025
- Business
- Yahoo
3 ASX Growth Companies With Up To 23% Insider Ownership
As the Australian market navigates a period of slower trade and investor caution amid ongoing global tensions, identifying growth companies with significant insider ownership can offer valuable insights into potential investment opportunities. In this environment, where confidence is tempered by geopolitical uncertainties, stocks with strong insider commitment may signal a higher level of trust in the company's long-term prospects. Name Insider Ownership Earnings Growth Alfabs Australia (ASX:AAL) 10.8% 41.3% Fenix Resources (ASX:FEX) 21.1% 47.8% Cyclopharm (ASX:CYC) 11.3% 97.8% Acrux (ASX:ACR) 15.5% 106.9% Newfield Resources (ASX:NWF) 31.5% 72.1% Echo IQ (ASX:EIQ) 19.8% 111.1% Titomic (ASX:TTT) 11.2% 77.2% Plenti Group (ASX:PLT) 12.7% 85% Image Resources (ASX:IMA) 16.1% 127.3% BETR Entertainment (ASX:BBT) 38.6% 77.5% Click here to see the full list of 93 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Aurelia Metals Limited is an Australian company involved in the exploration and production of mineral properties, with a market capitalization of A$456.99 million. Operations: The company's revenue is primarily derived from its operations at the Peak Mine (A$245.13 million), Dargues Mine (A$73.90 million), and Hera Mine (A$5.98 million). Insider Ownership: 23.9% Aurelia Metals shows promise as a growth company with substantial insider ownership, evidenced by significant insider buying in recent months. The company has returned to profitability, reporting A$17.95 million net income for the half-year ending December 2024 compared to a loss previously. While gold and silver production declined, copper output increased significantly. Analysts forecast robust annual earnings growth of 23.6%, outpacing the broader Australian market's expected growth rate of 11.7%. Unlock comprehensive insights into our analysis of Aurelia Metals stock in this growth report. The valuation report we've compiled suggests that Aurelia Metals' current price could be quite moderate. Simply Wall St Growth Rating: ★★★★★☆ Overview: Clarity Pharmaceuticals Ltd is a clinical stage radiopharmaceutical company focused on research and development of radiopharmaceutical products in Australia and the United States, with a market cap of A$539.87 million. Operations: The company's revenue segment consists of Radiopharmaceutical Development, generating A$10.78 million. Insider Ownership: 17.8% Clarity Pharmaceuticals demonstrates strong growth potential, driven by its innovative Cu-SAR-bisPSMA platform for prostate cancer treatment. Recent trial advancements show promising efficacy and safety, with significant PSA reductions in heavily pre-treated participants. The FDA's Fast Track Designation supports accelerated development. Despite a net loss of A$23.58 million for the half-year ending December 2024, revenue grew to A$10.94 million from A$6.52 million year-over-year, with forecasts indicating rapid revenue growth exceeding market averages. Take a closer look at Clarity Pharmaceuticals' potential here in our earnings growth report. Our valuation report here indicates Clarity Pharmaceuticals may be overvalued. Simply Wall St Growth Rating: ★★★★★★ Overview: IperionX Limited is involved in the exploration and development of mineral properties in the United States, with a market capitalization of approximately A$900.03 million. Operations: IperionX Limited's revenue segments are not specified in the provided text. Insider Ownership: 19.2% IperionX is poised for significant growth, driven by its Titan Critical Minerals Project in Tennessee and strategic U.S. partnerships, including a USD 47.1 million government award to enhance the titanium supply chain. Despite recent shareholder dilution and a net loss of USD 16.24 million for the half-year ending December 2024, IperionX's revenue is forecast to grow rapidly, outpacing market averages with expected profitability within three years, supported by innovative technologies and substantial insider ownership. Click here to discover the nuances of IperionX with our detailed analytical future growth report. Our comprehensive valuation report raises the possibility that IperionX is priced higher than what may be justified by its financials. Click through to start exploring the rest of the 90 Fast Growing ASX Companies With High Insider Ownership now. Contemplating Other Strategies? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:AMI ASX:CU6 and ASX:IPX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
25-03-2025
- Business
- Yahoo
Fenix Resources contracts MACA for Beebyn-W11 iron ore project in Australia
Fenix Resources has signed a mining contract with MACA, a subsidiary of Thiess Group, to develop the Beebyn-W11 iron ore mine in Western Australia's mid-west region. This contract includes drill and blast, mining, crushing and screening operations, with site mobilisation scheduled to commence in the June 2025 quarter. It supports the company's strategy to increase its production capacity to four million tonnes per annum (mtpa) in 2025. All necessary mining approvals for the project are in place, including the approval of the mining proposal by the Department of Energy, Mines, Industry Regulation and Safety. Shipments from the new mine are due to begin during the September 2025 quarter, marking the launch of Fenix's third operating mine in the mid-west region. A key requirement for commencing production at the Beebyn-W11 project is the construction of a private haul road. The road will link the new mine to Fenix's existing operations at Iron Ridge and provide a direct connection to Fenix's port facilities in Geraldton. The construction of the haul road is set to begin this month, following the receipt of the Native Vegetation Clearing Permit. The Beebyn-W11 iron ore deposit has a total measured and indicated mineral resource estimate of 20.5 million tonnes (mt) at 61.3% iron. The definitive feasibility study completed in July 2024 underscores the project's potential for 'exceptional' returns over a seven-year mine life at a production rate of 1.5mtpa. In October 2023, Fenix secured exclusive rights to mine and export up to ten million dry tonnes of iron ore from Beebyn-W11 deposit. The deposit is part of the larger Sinosteel Midwest's Weld Range project and has a JORC ore reserve of 10mt at 62.2% iron. Fenix has also secured agreements with the Wajarri Yamaji Aboriginal Corporation and entered into a Deed of Covenant under the Native Title and Heritage Sustainable Benefits Agreement with Sinosteel and the Wajarri Yamaji People. In February 2025, Fenix Resources signed an agreement to acquire CZR Resources through an off-market takeover bid. "Fenix Resources contracts MACA for Beebyn-W11 iron ore project in Australia" was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
